OCUL R&D Expense Growth
Ocular Therapeutix Inc · R&D Expense Growth
OCUL R&D Expense Growth
Latest reported54.42%period ending
OCUL FY R&D Growth (YoY) (0.00% → 54.42%)
Latest values, visible window
High-resolution chart · PNG
OCUL r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 54.4216% | |
| 109.0492% | |
| 14.2026% | |
| 6.7468% | |
| 74.5417% | |
| -30.1696% | |
| 11.3125% | |
| 19.5434% | |
| 14.0957% | |
| 1.7061% | |
| 40.9481% | |
| 79.5189% | |
| -8.8648% | |
| 0% |